Type | Public |
---|---|
ISIN | INE634S01028 |
Industry | Pharmaceutical |
Founded | 1991 |
Founders |
|
Headquarters | , India [2] |
Area served | Worldwide |
Key people | |
Products | |
Revenue | ₹8,749 crore (US$1.1 billion) (FY23) [3] |
₹1,913 crore (US$240 million) (FY23) [3] | |
₹1,310 crore (US$160 million) (FY23) [3] | |
Number of employees | 16,000+ (2022) [4] |
Website | www |
Mankind Pharma is an Indian pharmaceutical and healthcare products company, headquartered in Delhi. The company has products in therapeutic areas ranging from antibiotics, to gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. [5] [6] [7]
As of 2023, Mankind Pharma had 25 factories and 6 R&D centres in India. [8] The company derived 97% of its operating revenue from the Indian market, [9] where it is reportedly the fourth largest pharmaceutical company by domestic sales. [8] Some of Mankind Pharma's consumer healthcare brands are the largest-selling in their respective categories, including Manforce in condoms, [10] Prega News in pregnancy test kits, [11] and Unwanted-72 in emergency contraception. [12]
Mankind Pharma was incorporated in 1991, and actively started its operations in 1995, with the contributions of two brothers, Ramesh C. Juneja and Rajeev Juneja, who established the company with a seed capital of ₹ 5,000,000. [13] [14] The company was started with 20 employees and launched in two states in the first year of its operation. [15] [16]
Mankind Pharma initially targeted price-sensitive drugs, with a focus on rural market; [17] its early products included antibacterial drug Zenflox and prescription antibiotic Moxikind CV, which were priced at a steep discount to the existing products in the market. [18] The company ventured into the over-the-counter segment in 2007, focusing primarily on sexual healthcare products. [19] [20]
The company acquired Magnet Labs Pvt. Ltd. to enter the antipsychotic segment in 2007. [21] It acquired Longifene-an appetite stimulant for children in January 2010 which was earlier a brand of UCB. [22]
In 2017, Mankind Pharma established Pathkind Labs, a provider of diagnostics and healthcare tests. [23]
In 2019, Mankind became the first Indian company and second only in the world to develop and launch Dydrogesterone, a drug used in high-risk pregnancies and infertility by the brand name Dydroboon. [24]
In 2022, Mankind acquired Panacea Biotec Pharma's domestic formulations brands in India and Nepal for ₹1,872 crore (US$230 million). [25] It then acquired a respiratory treatment product, and an infant skincare brand from Dr. Reddy's Laboratories. [26] It also bought a majority stake in the Ayurvedic and herbal products manufacturer, Upakarma Ayurveda. [27]
In 2022, the company entered agritech [28] and pet care segments. [29]
In April 2023, Mankind Pharma launched its initial public offering (IPO), with existing investors selling approx. ₹4,326 crore (US$540 million) worth of shares. [30]
Cipla Limited is an Indian multinational pharmaceutical company, headquartered in Mumbai. Cipla primarily develops medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and other medical conditions.
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology.
Perrigo Company plc is an American Irish–registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.
Hetero Drugs is an Indian pharmaceutical company and the world’s largest producer of anti-retroviral drugs. Hetero’s business includes APIs, generics, biosimilars, custom pharmaceutical services, and branded generics.
Zydus Lifesciences Limited, formerly known as Cadila Healthcare Limited, is an Indian multinational pharmaceutical company headquartered in Ahmedabad, which is primarily engaged in the manufacture of generic drugs. The company ranked 100th in the Fortune India 500 list in 2020.
Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
Bisleri International is an Indian multinational company which is best known for the eponymous brand of bottled water. The company was started in the 1970s by Ramesh Chauhan, and sells bottled water and soft drinks.
HLL Lifecare Limited (HLL) is an Indian healthcare product manufacturing company based in Thiruvananthapuram, Kerala, India. A Government of India-owned corporation.
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. Its active pharmaceutical products include baricitinib, brivaracetam, and dapaglifozin.
Emami Group is an Indian multinational conglomerate headquartered in Kolkata. The company caters to a number of niche categories in the personal care and healthcare segments.
Lupin Limited is an Indian multinational pharmaceutical company based in Mumbai. It is one of the largest generic pharmaceutical companies by revenue globally. The company's key focus areas include paediatrics, cardiovascular, anti-infectives, diabetology, asthma and anti-tuberculosis.
Elder Pharmaceuticals Ltd is a pharmaceutical company headquartered in Mumbai, Maharashtra. Its main activities include the manufacturing and marketing of prescription pharmaceutical brands, surgical and medical devices. Its largest presence in three therapeutic segments, Women's Healthcare, Wound Care and Nutraceuticals. It has 6 manufacturing plants in India & 1 in Nepal. It manufacture various dosage forms like tablets, capsules, syrups, injectables, topical creams and ointments.
Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad. It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing. It has 18 manufacturing plants, 15 in India and the rest in United Kingdom and Mexico. In the financial year 2019, 69% of the company's revenue came from international markets while 31% came from India.
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company headquartered in HITEC City, Hyderabad, India. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include AstraZeneca and Pfizer.
Ramesh C. Juneja is an Indian billionaire businessman and the Chairman of Mankind Pharma. He is one of the 100 richest Indians as per Forbes; his net worth was estimated to be $2.3 billion in 2019.
The Piramal Group is an Indian multinational conglomerate that has presence across various sectors such as healthcare, life sciences, drug discovery, financial services, alternative investment and real estate.
OYO Rooms, also known as OYO Hotels & Homes, is an Indian multinational hospitality chain of leased and franchised hotels, homes, and living spaces. Founded in 2012 by Ritesh Agarwal, OYO initially consisted mainly of budget hotels. As of January 2020, it has more than 43,000 properties and 1 million rooms across 800 cities in 80 countries.
Nykaa is an Indian e-commerce company headquartered in Mumbai. It sells beauty, wellness and fashion products through its website, mobile app, and over 100 physical stores. In 2020, it became the first Indian unicorn startup headed by a woman.
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients (APIs), generic formulations, custom synthesis (CDMO), biotechnology. veterinary APIs and agro chemicals. The company was founded in 2005 by Dr. Satyanarayana Chava.